News
Parkinson’s UK leadership team and people affected by the disease visited the University of Dundee to meet with local researchers to get an overview of the work that they do.
News
Parkinson’s UK leadership team and people affected by the disease visited the University of Dundee to meet with local researchers to get an overview of the work that they do.
Press release
University of Dundee spinout Amphista Therapeutics has been designated as one of the world’s most promising biotechnology companies.
Press release
Researchers from the University of Dundee have discovered a small molecule that helps to eliminate a Parkinson’s disease-causing protein
Press release
The University of Dundee and Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents, will partner to commercialise technology developed at Dundee that enhances the understanding of undruggable diseases.
Press release
All roads lead west for a University of Dundee scientist who is using pedal power to fund research into Parkinson’s disease.
Press release
University of Dundee spinout Amphista Therapeutics will work with global biopharmaceutical companies as part of strategic collaborations potentially worth more than $2 billion.
Press release
Mutations in PINK1 are the second most frequent cause of autosomal recessive early-onset Parkinson’s disease.
News
Amphista Therapeutics, the spin out company from the lab of Professor Alessio Ciulli, was awarded the ‘Financing Deal of the Year’ award 2021 at the Scrip Awards last month. This was in recognition of their $53M Series B funding.